Inhibitor of Indoleamine-2,3-Dioxygenase (IDO)
Copyright © Targeted News Service 2024
2024-04-30
ALEXANDRIA, Virginia, April 30 -- INVENTISBIO LLC, Short Hills, New Jersey has been assigned a patent (No. US 11969425 B2, initially filed Feb. 9, 2023) developed by Xing Dai, Short Hills, New Jersey, and Yaolin Wang, Short Hills, New Jersey, for "Inhibitor of indoleamine-2,3-dioxygenase (IDO)." . . .